Plasma interferon-γ and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock

Critical Care Medicine

Volumn 32, Issue 2, 2004, Pages 433-438

  Bjerre, Anna ^a   Brusletto, Berit ^a   Høiby, Ernst Arne ^b   Kierulf, Peter ^a   Brandtzaeg, Petter ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Interferon ; Interleukin 10; Neisseria meningitidis; Septic shock; Staphylococcus aureus; Streptococcus pneumoniae

Indexed keywords

RECOMBINANT CYTOKINE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CAUSE OF DEATH; CHILD; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FATALITY; GRAM POSITIVE BACTERIUM; HEAT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC DISEASE;

EID: 1242342724     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000104950.52577.97     Document Type: Article

References (34)

1. Billiau A: Interferon-gamma: Biology and role in pathogenesis. Adv Immunol 1996; 62: 61-130
2. Okamura H, Tsutsi H, Komatsu T, et al: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378:88-91
3. Lauw FN, Dekkers PE, te Velde AA, et al: Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis 1999; 179: 646-652
4. Oppmann B, Lesley R, Blom B, et al: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-725
5. Tennenberg SD, Weller JJ: Endotoxin activates T cell interferon-gamma secretion in the presence of endothelium. J Surg Res 1996; 63:73-76
6. Hesse DG, Tracey KJ, Fong Y, et al: Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988; 166:147-153
7. Heinzel FP: The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 1990; 145:2920-2924
8. Kohler J, Heumann D, Garotta G, et al: IFN-gamma involvement in the severity of Gram-negative infections in mice. J Immunol 1993; 151:916-921
9. Bucklin SE, Russell SW, Morrison DC: Participation of IFN-gamma in the pathogenesis of LPS lethality. Prog Clin Biol Res 1994; 388:399-406
10. Car BD, Eng VM, Schnyder B, et al: Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med 1994; 179:1437-1444
11. Sauter C, Wolfensberger C: Interferon in human serum after injection of endotoxin. Lancet 1980; 2:852-853
12. Langezaal I, Coecke S, Hartung T: Whole blood cytokine response as a measure of immunotoxicity. Toxicol In Vitro 2001; 15: 313-318
13. Suffredini A, O'Grady N. Pathophysiological Responses to Endotoxin in Humans. In: Endotoxin in Health and Disease. Brade H, Opal SM, Vogel SN, et al (Ed). New York, Marcel Dekker, 1999, pp 817-830
14. Brandtzaeg P, Kierulf P, Gaustad P, et al: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204
15. Brandtzaeg P, Øvstebø R, Kierulf P: Quantitative detection of bacterial lipopolysaccharides in clinical specimens. In: Meningococcal Disease Protocols. Pollard AJ, Maiden MCJ (Eds). Totowa, NJ, Humana Press, 2001, pp 427-439
16. Brandtzaeg P, Bjerre A, Øvstebo R, et al: Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 2001; 7:401-420
17. Girardin E, Grau GE, Dayer JM. et al: Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988; 319:397-400
18. Waage A, Brandtzaeg P, Halstensen A, et al: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169:333-338
19. Hazelzet JA, Kornelisse RF, van der Pouw Kraan TC, et al: Interleukin 12 levels during the initial phase of septic shock with purpura in children: Relation to severity of disease. Cytokine 1997; 9:711-716
20. Waldvogel FA: Staphylococcus aureus (including staphylococcal toxic shock). In: Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R (Eds). Philadelphia, Churchill Livingstone, 2000, pp 2069-2092
21. Brandtzaeg P, Osnes L, Øvstebø R, et al: Net inflammatory capacity of human septic shock plasma as evaluated by a monocyte target-based cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 1996; 184:51-60
22. Rosenqvist E, Hoiby EA, Wedege E, et al: Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun 1995; 63: 4642-4652
23. Waage A, Halstensen A, Espevik T: Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1:355-357
24. Halstensen A, Ceska M, Brandtzaeg P, et al: Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis 1993; 167:471-475
25. Lehmann AK, Halstensen A, Sornes S, et al: High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun 1995; 63:2109-2112
26. Calandra T, Baumgartner JD, Grau GE, et al: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990; 161:982-987
27. Pollard AJ, Galassini R, van der Voort EMR, et al: Cellular immune responses to Neisseria meningitides in children. Infect Immun 1999; 67:2452-2463
28. Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-173
29. Fiorentino DF, Zlotnik A, Vieira P, et al: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146:3444-3451
30. de Vries JE: Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 1995; 27:537-541
31. Opal SM, Wherry JC, Grint P: Interleukin-10: Potential benefits and possible risks in clinical infectious diseases. Clin Infect Dis 1998; 27:1497-1507
32. Ferguson NR, Galley HF, Webster NR: T helper cell subset ratios in patients with severe sepsis. Intensive Care Med 1999; 25: 106-109
33. Lauw FN, ten Hove T, Dekkers PE, et al: Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin. Infect Immun 2000; 68:1014-1018
34. Westendorp RGJ, Langemans JAM, Huizinga TWJ, et al: Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349:170-173